共 183 条
[1]
Bray F(2018)Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J Clin 68 394-424
[2]
Ferlay J(2020)Guidelines for the diagnosis and treatment of hepatocellular carcinoma (2019 edition) Liver Cancer 9 682-720
[3]
Soerjomataram I(2019)A global view of hepatocellular carcinoma: trends, risk, prevention and management Nat Rev Gastroenterol Hepatol 16 589-604
[4]
Zhou J(2018)Hepatocellular carcinoma Lancet 391 1301-1314
[5]
Sun H(2020)Single-cell landscape of the ecosystem in early-relapse hepatocellular carcinoma Cell 249 118-123
[6]
Wang Z(2009)Solitary large hepatocellular carcinoma: a specific subtype of hepatocellular carcinoma with good outcome after hepatic resection Ann Surg 272 574-581
[7]
Yang JD(2020)Overall tumor burden dictates outcomes for patients undergoing resection of multinodular hepatocellular carcinoma beyond the Milan criteria Ann Surg 156 477-91 e1
[8]
Hainaut P(2019)Epidemiology and management of hepatocellular carcinoma Gastroenterology 49 3412-3419
[9]
Gores GJ(2013)Regorafenib as second-line therapy for intermediate or advanced hepatocellular carcinoma: multicentre, open-label, phase II safety study EurJ Cancer (Oxford, England: 1990) 56 1330-1335
[10]
Forner A(2012)Survival of patients with hepatocellular carcinoma treated by transarterial chemoembolisation (TACE) using Drug Eluting Beads. Implications for clinical practice and trial design J Hepatol 74 96-108